Iovance Biotherapeutics, Inc. Financial Ratios — IOVA Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-38.54	-37.16	-75.55	-58.94	-40.41	-51.64	-54.34	-53.55	-70.61	-81.91	-57.48	-55.5
Return on Assets (%)	-2,532.21	-1,106.52	-255.06	-36.26	-36.36	-38.12	-56.26	-38.85	-47.86	-46.64	-44.28	-54.93	-61.49	-44.02	-42.88
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.12	43.17	34.28
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-35,948.86	-211.62	-133.16
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-38,734.99	-240.92	-151.12
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-37,638.02	-228.56	-149.16
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-37,345.42	-226.84	-148.38
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-37,345.42	-226.84	-148.38
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	25	- -	- -	48.32	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-38.54	-37.16	-39.05	-58.94	-40.41	-51.64	-54.34	-53.55	-70.61	-81.91	-57.48	-55.5

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	5	6	- -	- -	- -	- -	- -	- -	12	52	72	85	76	58	49
ST Debt	5	6	- -	- -	- -	- -	- -	- -	7	6	5	13	8	13	5
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	4	45	66	73	68	45	44
Total Debt/EBITDA	-0.24	-0.8	- -	- -	- -	- -	- -	- -	-0.06	-0.2	-0.22	-0.23	-0.18	-0.17	-0.14
Net Debt/EBITDA	-0.21	-0.8	0.87	3.76	1.25	2.03	1.58	0.65	0.07	0.27	0.23	0.61	0.27	0.33	0.46
Total Debt/EBIT	-0.24	-0.8	- -	- -	- -	- -	- -	- -	-0.06	-0.2	-0.21	-0.21	-0.16	-0.15	-0.12
Net Debt/EBIT	-0.21	-0.8	0.87	3.73	1.21	1.99	1.57	0.64	0.07	0.26	0.23	0.58	0.25	0.29	0.41
EBITDA to Interest Expense	-4.09	-3.36	-50.89	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-4.09	-3.36	-50.92	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	-4.09	-3.36	-50.91	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	5	2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-2,248.46	-38,484.6	88.58	96.43	98.46	97.11	93.63	96.96	86.74	85.43	79.97	75.25	74.92	78.03	76.5
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	1.42	6.91	10.69	14.58	11.65	6.39	6.36
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	1.37	6.41	9.59	12.45	10.31	5.9	5.94
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	1.23	5.9	8.55	10.97	8.72	4.98	4.86
Total Debt/Equity (%)	-39.12	-57.26	- -	- -	- -	- -	- -	- -	3.85	7.87	11.51	17.1	12.98	8.2	7.08
Total Debt/Capital (%)	-64.26	-133.96	- -	- -	- -	- -	- -	- -	3.7	7.29	10.32	14.6	11.49	7.58	6.61
Total Debt/Total Assets (%)	879.62	22,035.32	- -	- -	- -	- -	- -	- -	3.34	6.72	9.2	12.87	9.72	6.4	5.41
Net Debt to Equity	-35.13	-57.26	-111.75	-100.14	-32.29	-63.93	-99.93	-17.62	-4.67	-10.26	-12.42	-46.18	-19.48	-16.14	-23.2
Net Debt/Capital (%)	-54.15	-133.96	951.05	70,170.31	-47.68	-177.27	-134,604.63	-21.39	-4.71	-10.51	-12.56	-65.3	-20.87	-17.56	-27.71
EBITDA	-21	-8	-23	-12	-27	-53	-92	-127	-199	-253	-329	-378	-427	-347	-351
EBITDA-CapEx	-21	-8	-23	-14	-28	-54	-93	-128	-206	-300	-366	-398	-450	-358	-385
Operating Income (Loss)	-21	-8	-23	-12	-28	-54	-93	-128	-207	-262	-343	-399	-461	-395	-398

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.04	- -	8.67	27.02	63.62	33.51	15.15	32.54	7.86	11.47	5.65	5.16	2.54	2.65	2.15
Current Ratio	0.04	- -	8.74	27.06	63.79	34.12	15.56	33.02	8.1	11.59	5.69	5.24	2.79	3.74	3.2
Quick Ratio	0.04	- -	8.67	27.02	63.62	33.51	15.15	32.54	7.86	11.47	5.65	5.16	2.54	3.21	2.74
CFO/Avg Current Liab	-0.87	-0.18	-0.54	-4.39	-11.17	-9.9	-10.81	-8.44	-5.94	-4.37	-3.16	-3.24	-3.59	-3.03	-2.32
Common Equity/Total Assets	-2,248.46	-38,484.6	88.58	96.43	98.46	97.11	93.63	96.96	86.74	85.43	79.97	75.25	74.92	78.03	76.5
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	1.42	6.91	10.69	14.58	11.65	6.39	6.36
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	1.37	6.41	9.59	12.45	10.31	5.9	5.94
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	1.23	5.9	8.55	10.97	8.72	4.98	4.86
Total Debt/Equity (%)	-39.12	-57.26	- -	- -	- -	- -	- -	- -	3.85	7.87	11.51	17.1	12.98	8.2	7.08
Total Debt/Capital (%)	-64.26	-133.96	- -	- -	- -	- -	- -	- -	3.7	7.29	10.32	14.6	11.49	7.58	6.61
Total Debt/Total Assets (%)	879.62	22,035.32	- -	- -	- -	- -	- -	- -	3.34	6.72	9.2	12.87	9.72	6.4	5.41
CFO/Total Liabilities	-46.36	-19.75	-161.28	-519.43	-1,127.67	-657.57	-795.68	-692.16	-347.8	-183.22	-146.42	-178.14	-184.85	-176.47	-140.93
CFO/CapEx	-199.31	- -	-281.62	-5.42	-16.08	-21.48	-76.57	-84.52	-22.97	-4.38	-6.07	-14.33	-16.23	-31.89	-8.94
Altman's Z-Score	-213.25	-2,834.71	48.33	93.85	136.87	51.09	32.36	43.99	42.62	34.79	8.63	-0.21	-1.05	0.28	-4.07

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	15.75	4.72	3.47
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	23.18	77.3	105.13
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.2	3.01	3.36
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,832.42	121.13	108.75
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.38	4.43	6.98
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	955.72	82.33	52.29
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	899.88	116.09	161.58
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,809.24	-43.83	-3.62
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	10	52	52
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	28	32
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6	9	5
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5	15	23
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-8

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	78	18	210	266	375	433	585	1,092	3,499	6,815	2,997	1,200	2,082	2,259	1,125
- Cash & Cash Equivalents	1	- -	20	45	34	107	145	82	14	67	78	232	115	116	163
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	5	6	- -	- -	- -	- -	- -	- -	12	52	72	85	76	58	49
Enterprise Value	82	24	191	221	271	266	440	624	3,204	6,237	2,564	814	1,878	1,993	877
Total Capital	-8	-5	18	45	104	167	145	466	310	708	693	585	660	769	748
Total Debt/Capital (%)	-64.26	-133.96	- -	- -	- -	- -	- -	- -	3.7	7.29	10.32	14.6	11.49	7.58	6.61
Total Debt / EV	0.06	0.26	- -	- -	- -	- -	- -	- -	- -	0.01	0.03	0.11	0.04	0.03	0.06
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,579.8	12.15	3.33
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	137.24	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	137.24	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	76	18	103	197	343	384	522	861	3,442	6,417	2,929	1,018	1,912	2,145	976
Diluted Enterprise Value	80	24	83	152	309	277	377	779	3,439	6,402	2,922	871	1,873	2,088	862
EV per Share	105.74	29.92	9.52	6.54	5.58	4.28	6.01	5.05	25.34	42.47	16.33	4.33	7.33	6.53	2.13
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	164	264
TTM EBITDA	-21	-8	-23	-12	-27	-53	-92	-127	-199	-253	-329	-378	-427	-347	-351
TTM Operating Income	-21	-8	-23	-12	-28	-54	-93	-128	-207	-262	-343	-399	-461	-395	-398
TTM Cash Flow to Firm	-1	- -	-3	-9	-18	-33	-79	-101	-159	-205	-228	-293	-362	-353	-302
TTM Free Cash Flow to Firm	-1	- -	-3	-7	-17	-31	-78	-100	-152	-158	-190	-272	-340	-342	-269

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-12.33	-7.84	-28.1	-27.93	-19.89	-12.33	-6.72	-8.6	-22.65	-40.53	-15.38	-3.74	-5.63	-6.27	-3.63
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	82	24	191	221	271	266	440	624	3,204	6,237	2,564	814	1,878	1,993	877
Low Price	78	13	1	4.75	5.27	4.24	4.45	7.26	8.26	18.7	15.88	5.42	3.21	7.05	1.64
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,579.8	12.15	3.33
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-3.54	-16.59	-1.67	-14.74	-14.11	-3.67	-4.97	-10.54	-11.02	-17.31	-12.6	-4.81	-3.42	-7.99	-2.79
Price/Earnings High	-4.88	-32.59	-5.77	-23.36	-24.13	-5.17	-6.76	-15.66	-18.68	-27.93	-24.3	-7.91	-4.96	-14.28	-7.45
Price/Earnings Low	-2.3	-3.14	-0.29	-9.86	-8.46	-2.29	-3.15	-5.71	-5.2	-9.96	-7.12	-2.18	-1.7	-5.49	-1.5
Price/Book Value	-6.1	-1.59	11.94	5.92	3.6	2.59	4.02	2.34	11.7	10.38	4.82	2.4	3.56	3.18	1.61
Price/Book Value Average	-7.31	-4.97	6.59	5.34	4.1	2.53	3.53	3.55	7.4	7.27	7.1	4.49	2.83	4.41	1.8
Price/Book Value High	-10.07	-9.77	22.75	8.47	7.01	3.57	4.8	5.27	12.55	11.73	13.69	7.39	4.1	7.88	4.81
Price/Book Value Low	-4.76	-0.94	1.14	3.57	2.46	1.58	2.24	1.92	3.49	4.18	4.01	2.04	1.41	3.03	0.97
Price/Tangible Book Value	-6.1	-1.59	11.94	5.92	3.6	2.59	4.02	2.34	11.7	10.38	4.82	2.4	5.86	5.28	2.68
Price/Tangible Book Value Average	-7.31	-4.97	6.59	5.34	4.1	2.53	3.53	3.55	7.4	7.27	7.1	4.49	4.65	7.32	3
Price/Tangible Book Value High	-10.07	-9.77	22.75	8.47	7.01	3.57	4.8	5.27	12.55	11.73	13.69	7.39	6.75	13.07	8.01
Price/Tangible Book Value Low	-4.76	-0.94	1.14	3.57	2.46	1.58	2.24	1.92	3.49	4.18	4.01	2.04	2.31	5.03	1.61
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,607.75	13.07	3.7
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,275.49	18.12	4.14
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,850.99	32.39	11.05
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	634.79	12.46	2.22
Price/Cash Flow	-12.27	-7.84	-28	-22.78	-18.65	-11.76	-6.63	-8.5	-21.66	-31.28	-12.85	-3.48	-5.28	-6.08	-3.23
Price/Cash Flow Average	-14.7	-24.48	-15.44	-20.55	-21.23	-11.48	-5.81	-12.87	-13.7	-21.9	-18.92	-6.5	-4.19	-8.42	-3.61
Price/Cash Flow High	-20.24	-48.09	-53.33	-32.56	-36.31	-16.21	-7.91	-19.12	-23.23	-35.35	-36.48	-10.69	-6.08	-15.05	-9.63
Price/Cash Flow Low	-9.57	-4.63	-2.67	-13.75	-12.73	-7.17	-3.69	-6.98	-6.46	-12.61	-10.69	-2.95	-2.09	-5.79	-1.94
Price/Free Cash Flow Average	-14.77	-24.48	-15.5	-25.19	-22.64	-12.05	-5.89	-13.02	-14.33	-28.37	-22.65	-6.99	-4.47	-8.7	-4.06
Price/Free Cash Flow High	-20.34	-48.09	-53.52	-39.92	-38.72	-17	-8.01	-19.35	-24.28	-45.79	-43.68	-11.5	-6.48	-15.54	-10.84
Price/Free Cash Flow Low	-9.62	-4.63	-2.68	-16.86	-13.58	-7.52	-3.74	-7.06	-6.76	-16.33	-12.8	-3.17	-2.22	-5.98	-2.18
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,356.61	18.73	4.34
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,983.52	33.75	12.31
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	658.68	12.77	2.13
EV/EBITDA Average	-4.65	-7.72	-4.25	-16.29	-14.63	-6	-4	-12.34	-11.12	-18.78	-13.4	-5.56	-3.77	-8.85	-3.26
EV/EBITDA High	-6.33	-14.4	-16.82	-28.01	-25.91	-9.3	-6.01	-18.65	-18.87	-30.35	-25.87	-9.39	-5.52	-15.95	-9.24
EV/EBITDA Low	-3.1	-2.11	-0.02	-9.65	-8.27	-2.99	-1.96	-6.39	-5.24	-10.78	-7.56	-2.31	-1.83	-6.03	-1.6
EV/EBIT Average	-4.65	-7.71	-4.25	-16.17	-14.11	-5.89	-3.96	-12.24	-10.69	-18.15	-12.86	-5.26	-3.5	-7.78	-2.87
EV/EBIT High	-6.32	-14.39	-16.82	-27.8	-24.99	-9.13	-5.95	-18.51	-18.12	-29.34	-24.82	-8.89	-5.12	-14.01	-8.15
EV/EBIT Low	-3.1	-2.11	-0.02	-9.58	-7.98	-2.93	-1.94	-6.35	-5.04	-10.43	-7.26	-2.19	-1.7	-5.3	-1.41
Last Price	100	22	10.5	7.87	7.72	6.95	8	8.85	27.68	46.4	19.09	6.39	8.13	7.4	2.73
High Price	165	135	20	11.25	15.03	9.58	9.54	19.9	29.68	52.43	54.21	19.66	9.36	18.33	8.15
Enterprise Value Average	98	63	96	195	393	316	368	1,571	2,211	4,755	4,406	2,099	1,613	3,074	1,143
Enterprise Value High	133	117	381	335	696	490	553	2,374	3,749	7,685	8,505	3,546	2,358	5,538	3,244
Enterprise Value Low	65	17	- -	115	222	157	180	814	1,042	2,731	2,487	872	783	2,095	562

Shares Outstanding	1	1	20	34	49	62	73	123	126	147	157	188	256	305	412
Diluted Weighted Avg Shares	1	1	10	25	44	55	65	97	124	138	153	159	235	290	357
Basic Weighted Avg Shares	1	1	10	25	44	55	65	97	124	138	153	159	235	290	357
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.01	0.57	0.74
EBITDA per Share	-27.73	-10.18	-2.32	-0.48	-0.6	-0.95	-1.41	-1.31	-1.6	-1.83	-2.14	-2.37	-1.82	-1.2	-0.98
Operating Income per Share	-27.74	-10.18	-2.32	-0.48	-0.63	-0.97	-1.42	-1.32	-1.66	-1.89	-2.23	-2.5	-1.96	-1.36	-1.11
Basic EPS, GAAP	-33.84	-4.14	-3.47	-0.48	-0.62	-1.85	-1.41	-1.27	-1.59	-1.88	-2.23	-2.49	-1.89	-1.28	-1.09
Basic EPS from Cont Ops	-33.84	-4.14	-2.6	-0.48	-0.62	-0.96	-1.41	-1.27	-1.59	-1.88	-2.23	-2.49	-1.89	-1.28	-1.09
Diluted EPS, GAAP	-33.84	-4.14	-3.47	-0.48	-0.62	-1.85	-1.41	-1.27	-1.59	-1.88	-2.23	-2.49	-1.89	-1.28	-1.09
Diluted EPS from Cont Ops	-33.84	-4.14	-2.6	-0.48	-0.62	-0.96	-1.41	-1.27	-1.59	-1.88	-2.23	-2.49	-1.89	-1.28	-1.09
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-8.15	-2.81	-0.38	-0.35	-0.41	-0.59	-1.21	-1.04	-1.28	-1.48	-1.49	-1.84	-1.54	-1.22	-0.85
Free Cash Flow per Basic Share	-8.19	-2.81	-0.38	-0.41	-0.44	-0.62	-1.22	-1.05	-1.33	-1.82	-1.73	-1.97	-1.63	-1.26	-0.94
Cash & Equivalents per Share	0.67	- -	0.98	1.33	2.14	2.67	1.99	3.8	2.43	4.29	3.21	2.51	1.09	1.06	0.72
Book Value per Share	-16.39	-13.82	0.88	1.33	2.14	2.68	1.99	3.78	2.37	4.47	3.96	2.66	2.28	2.33	1.7
Tangible Book Value per Share	-16.39	-13.82	0.88	1.33	2.14	2.68	1.99	3.78	2.37	4.47	3.96	2.66	1.39	1.4	1.02

Iovance Biotherapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)